Results 241 to 250 of about 5,730,128 (298)
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors. [PDF]
J Cancer Res Clin OncolSperber L +12 more
europepmc +1 more source
Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors. [PDF]
Cancers (Basel)Khan MW +4 more
europepmc +1 more source
Comment on "Treatment Outcomes and Prognostic Factors of Intracranial Germ Cell Tumors". [PDF]
Brain Tumor Res TreatDaungsupawong H, Wiwanitkit V.
europepmc +1 more source
To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm [PDF]
International Journal of Molecular Sciences, 2021 In the human embryo, the genetic program that orchestrates germ cell specification involves the activation of epigenetic and transcriptional mechanisms that make the germline a unique cell population continuously poised between germness and pluripotency. Germ cell tumors, neoplasias originating from fetal or neonatal germ cells, maintain such dichotomy
Francesca Gioia Klinger +2 more
exaly +7 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2007
Testicular cancer is rare, accounting for 1% to 2% of all male malignancies. Nearly 90% to 95% of tumors arising in testis are germ cell in origin. Other sites of malignant germ cell tumors include the retroperitoneum, mediastinum, sacrococcygeal region, and pineal gland. The highest incidence is seen in Scandinavian countries, particularly Denmark (1).
De Giorgi U, Pedrazzoli P, Rosti G
openaire +1 more source
Testicular cancer is rare, accounting for 1% to 2% of all male malignancies. Nearly 90% to 95% of tumors arising in testis are germ cell in origin. Other sites of malignant germ cell tumors include the retroperitoneum, mediastinum, sacrococcygeal region, and pineal gland. The highest incidence is seen in Scandinavian countries, particularly Denmark (1).
De Giorgi U, Pedrazzoli P, Rosti G
openaire +1 more source
Cancer Treatment Reviews, 2008 Malignant ovarian germ cell tumors (MOGCTS) are rare but curable at all stages of disease. This review gives an outline of the management of this disease.We performed a literature search in the PubMed of almost all relevant articles concerning MOGCTs on pathology, prognostic factors, surgery, post-operative therapy and late effects of therapy.
D Kassanos, D Pectasides
exaly +4 more sources
Hematology/Oncology Clinics of North America, 1992
Although the remarkable progress in the pathology of ovarian germ cell tumors which was achieved during the preceding three decades did not proceed at the same rapid pace during the 1980s, the past decade not only witnessed the accumulation of new knowledge, but was also characterized by the consolidation, expansion, and wider application of the ...
openaire +4 more sources
Although the remarkable progress in the pathology of ovarian germ cell tumors which was achieved during the preceding three decades did not proceed at the same rapid pace during the 1980s, the past decade not only witnessed the accumulation of new knowledge, but was also characterized by the consolidation, expansion, and wider application of the ...
openaire +4 more sources
Hematology/Oncology Clinics of North America, 2011
Testicular cancer has been a model for a curable malignancy. The existence of an array of potential new therapies is the result of a prodigious effort in the researching and defining of the molecular components of the cancer phenotype and the subsequent rational design of agents to target candidate pathways.
Yuk Ting, Ma +2 more
openaire +2 more sources
Testicular cancer has been a model for a curable malignancy. The existence of an array of potential new therapies is the result of a prodigious effort in the researching and defining of the molecular components of the cancer phenotype and the subsequent rational design of agents to target candidate pathways.
Yuk Ting, Ma +2 more
openaire +2 more sources
Germ Cell Tumors of the Testis
Annals of Surgical Oncology, 2005Testicular cancer is the most common malignancy in men aged 20 to 35 years and accounts for approximately 1% of all male malignancies. Through the appropriate utilization of clinical trials, effective treatment paradigms have been developed for the management of all stages of testicular cancer.
Brett S, Carver, Joel, Sheinfeld
openaire +2 more sources